liquid pharma

Hey guys, i received a price list recently and i saw on there liquid pharma hexarelin and cjc, i think i also saw igf from them. The prices were really good as well. I thought they only make orals? have they started to make peptides as well?

its exciting hey cant wait to get my hands on some peptides in the new year

spartacus wrote: Hey guys, i received a price list recently and i saw on there liquid pharma hexarelin and cjc, i think i also saw igf from them. The prices were really good as well. I thought they only make orals? have they started to make peptides as well?

Funny that you should ask this, because I was told last week that LP will not sell peptides under their name anymore starting next week.

Liquid-Pharma doesn't make the peptides, but they obtain them from a partner in China that produce really good quality peptides. Those products will now be sold under a new brand to avoid this confusion and to help create a more stable supply.


Sent from my iPad using Tapatalk HD

thanx for clearing that up admin, i was really impressed with the prices hey

admin wrote:

spartacus wrote: Hey guys, i received a price list recently and i saw on there liquid pharma hexarelin and cjc, i think i also saw igf from them. The prices were really good as well. I thought they only make orals? have they started to make peptides as well?

Funny that you should ask this, because I was told last week that LP will not sell peptides under their name anymore starting next week.

Liquid-Pharma doesn't make the peptides, but they obtain them from a partner in China that produce really good quality peptides. Those products will now be sold under a new brand to avoid this confusion and to help create a more stable supply.


Sent from my iPad using Tapatalk HD

Does this mean that LP might start a wider range of ghrp's and other peptides under the new brand?

LP's peptides did not make much money for LP's distributors and they were only sold to satisfy the demands of clients.

The separation from the Liquid-Pharma brand will help the range to expand and stabilise supply.

This is good news to us the endusers as peptides were considered a secondary market by LP and that caused the main business of oral products to take priority at the expense of the peptides.